©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Apr 26, 2022; 14(4): 206-219
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.206
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.206
Cardiac myxomas: A narrative review
A K M Monwarul Islam, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka 1207, Bangladesh
Author contributions: Islam AKMM conceptualized the review and wrote and approved the manuscript.
Conflict-of-interest statement: All authors declare having no conflicts of interest.
Corresponding author: A K M Monwarul Islam, MD, FCPS, FACC, FESC, FASE, FACP, FRCP, Associate Professor, Department of Cardiology, National Institute of Cardiovascular Diseases, Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh. drmonwarbd@yahoo.com
Received: March 18, 2021
Peer-review started: March 18, 2021
First decision: July 18, 2021
Revised: August 28, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: April 26, 2022
Processing time: 396 Days and 8.7 Hours
Peer-review started: March 18, 2021
First decision: July 18, 2021
Revised: August 28, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: April 26, 2022
Processing time: 396 Days and 8.7 Hours
Core Tip
Core Tip: Cardiac myxomas are biologically benign but “functionally malignant”. They can cause life-threatening embolic events. Associated constitutional symptoms may mimic those of inflammatory or connective tissue disorders. Timely diagnosis is of utmost importance because it offers a scope for definitive treatment, i.e. surgical excision. Cardiac myxoma is a relatively rare diagnosis, so physicians should have appropriate preparedness to deal with this entity. This review article has summarised the available information, offered practical tips and highlighted the recent advances.